v3.26.1
STOCKHOLDERS' EQUITY (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Summary of Stock Option Activity

The following table summarizes the changes in the Company’s outstanding stock options for the three months ended March 31, 2026:

 

 

Number of
Options

 

 

Weighted Average Exercise Price

 

Outstanding at January 1, 2026

 

 

15,524,201

 

 

$

1.36

 

Granted

 

 

 

 

$

 

Exercised

 

 

(44,788

)

 

$

0.95

 

Forfeited / Cancelled / Expired

 

 

(142,610

)

 

$

1.28

 

Outstanding at March 31, 2026

 

 

15,336,803

 

 

$

1.36

 

Summary of Restricted Stock Unit Activity

The following table summarizes the changes in the Company’s outstanding RSUs for the three months ended March 31, 2026:

 

 

Number of
RSUs

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at January 1, 2026

 

 

2,788,214

 

 

$

0.76

 

Granted

 

 

3,531,678

 

 

$

1.08

 

Released

 

 

(575,651

)

 

$

0.77

 

Forfeited

 

 

(36,312

)

 

$

0.74

 

Outstanding at March 31, 2026

 

 

5,707,929

 

 

$

0.96

 

Summary of Stock-Based Compensation Expenses by Function

The Company’s stock-based compensation expenses for the periods presented were as follows:

 

 

Three Months Ended
March 31,

 

 

 

2026

 

 

2025

 

Cost of sales

 

$

17

 

 

$

18

 

Research and development

 

 

238

 

 

 

345

 

Sales and marketing

 

 

62

 

 

 

63

 

General and administrative

 

 

330

 

 

 

519

 

Total stock-based compensation expense

 

$

647

 

 

$

945